The growing cohort of seniors with HIV/AIDS: Changing the scope of Medicare Part D

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 22, Issue 7, 2010, Pages 903-908

  Flaer, Paul J ^a,b   Benjamin, Paul L ^b   Malow, Robert M ^a   Morisky, Donald E ^c   Parkash, Jai ^a  

^a FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^b Dade County   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ARV HAART; cost sharing tiers; HIV AIDS; Medicare Part D; opportunistic infections

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; ACICLOVIR; ATAZANAVIR; ATOVAQUONE; AZITHROMYCIN; CIDOFOVIR; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ENFUVIRTIDE; ETHAMBUTOL; FAMCICLOVIR; FANSIDAR; FLUCONAZOLE; FOLINATE CALCIUM; FOSAMPRENAVIR; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; ISONIAZID; ITRACONAZOLE; LOPINAVIR PLUS RITONAVIR; METOCORTEN; PANASOL; PENTAMIDINE ISETHIONATE; PREDNICE M; PREDNISONE; PROBENECID; PYRAZINAMIDE; PYRIMETHAMINE; RALTEGRAVIR; RIBAVIRIN; RIFABUTIN; RIFAMPICIN; RITONAVIR; SPORONOX; STERAPRED; SULFADIAZINE; SULFADOXINE PLUS TRIMETHOPRIM; TRIZAVIR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALACICLOVIR; VALGANCICLOVIR; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COHORT ANALYSIS; COMORBIDITY; COST CONTROL; DRUG COST; HEALTH CARE COST; HEALTH CARE PERSONNEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MEDICARE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGE FACTORS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COST CONTROL; COST SHARING; HEALTH CARE REFORM; HEALTH EXPENDITURES; HEALTH SERVICES ACCESSIBILITY; HEALTH TRANSITION; HUMANS; MEDICARE PART D; UNITED STATES;

EID: 77954699488     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120903499188     Document Type: Review

References (31)

1. Antos, J., & Gokhale, J. (2005). Medicare prescription drugs: Medical necessity meets fiscal insanity. Briefing Paper no. 91. Retrieved August 10, 2008, from http:// www.cato.org/pub-display.php?pub-id-3671.
2. AVERT (2008). AVERTing HIV and AIDS: Older people, HIV and AIDS. Retrieved June 25, 2008, from http:// www.avert.org/older-people.htm.
3. AVERT (2009). HIV and AIDS in Africa. Retrieved July 30, 2009, from http://www.avert.org/aafrica.htm.
4. Bastos, F.I., Nunn, A., Hacker, M.A., Malta, M., & Szwarcwald, C.L. (2008). Chapter 29: AIDS in Brazil: The challenge and the response. In D.D. Celentano & C. Beyrer (Eds.), Public health aspects of HIV/AIDS in low and middle income countries: Epidemiology, prevention and care (pp. 629-654). New York, NY: Springer.
5. Brill, J.V. (2007). Trends in the prescription drug plans delivering the Medicare Part D prescription drug benefit. Retrieved July 2, 2008, from http://www.ajhp.org/cgi/ content/ abstract/64/15-Supplement-10/S3.
6. Buckley, R.H. (2006). Human immunodeficiency virus. In M.R. Beers, R.S. Porter, T.V. Jones, J.L. Kaplan, & M. Berkwits (Eds.), Merck manual of diagnosis and therapy: Eighteenth edition (pp. 1625-1642). Whitehouse Station, NJ: Merck Research Labs.
7. Cardarelli, W.J. (2008). Complexities and challenges in managed care. Journal of Managed Care Pharmacy, 14(5), S17-S20.
8. CDC (2008). AIDS coverage gaps linger in Medicare. Retrieved July 1, 2008, from http://www.thebody. com/content/news/art47163.html?mtrk-8639252.
9. CDC (2009). AIDS cases by age. Retrieved October 14, 2009, from http://www.cdc.gov/hiv/topics/surveil lancde/basic.htm.
10. Centers for Medicare & Medicaid Services (2008). Medicare & you. Baltimore, MD: United States Department of Health and Human Services.
11. Chao, S.H. (2008). Epidemiology, economic burden, and risk factors of chronic viral diseases. Journal of Managed Care Pharmacy, 14(5), S4-S6.
12. Community CCRx Formulary (2008). 2009 formulary: Complete list of covered drugs. Rensselaer, NY: Universal American.
13. Das-Douglas, M., Riley, E.D., Ragland, K., Guzman, D., Clark, R., Kushel, M.B., et al. (2007). Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruption. Paper presented at the 2nd International Conference on HIV Treatment Adherence, Jersey City, NJ.
14. DePue, R., & Stubbings, J. (2008). Medicare Part D: Selected issues for plan sponsors, pharmacists, and beneficiaries in 2008. Journal of Managed Care Pharmacy, 14(1), 50-60.
15. Gebo, K.A., & Justice, A. (2009). HIV infection in the elderly. Current Infectious Disease Reports, 11, 246-264.
16. Grinspoon, S.K., Grunfeld, C., Kotler, D., Currier, J.S., Lundgren, J.D., Dube, M.P., et al. (2008). Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: Executive summary. Circulation, 118(2), 198-210.
17. Humana (2009). 2009 prescription drug guide: Humana formulary list of covered drugs. Retrieved April 19, 2009, from http://apps.humana.com/Marketing/ documents.asp?file-1061034.
18. Kaiser Family Foundation (2004). Dual eligibles: Medicaid's role for low-income Medicare beneficiaries. Retrieved July 25, 2009, from http://www.kff.org/medicaid/up load/Dual-Eligibles-Medicaid-s-Role-for-Low- Income-Medicare-Beneficiaries-Fact-Sheet-2.pdf.
19. Kaiser Family Foundation (2006). The role of Part D for people with HIV/AIDS: Coverage and cost of antiretrovirals under Medicare drug plans. Medicare Drug Benefit, report #7548. Retrieved July 1, 2008, from http://www.kff.org/hivaids/7548.cfm.
20. Kaiser Family Foundation (2007). Medicare: Primer, report #7615. Retrieved June 9, 2008, from http:// www.kff.org/medicare/7615.cfm.
21. Kaiser Family Foundation (2008). The Medicare Part D coverage gap: Costs and consequences in 2007. Retrieved October 9, 2008, from http://www.kff.org/ medicare/7811.cfm.
22. Lieberman, R. (2000). HIV in older Americans: An epidemiologic perspective. Journal of Midwifery & Women's Health, 45(2), 176-182.
23. Louisiana ADAP Formulary (2008). Louisiana AIDS Drug Assistance Program Formulary. Retrieved April 19, 2009, from http://www.dhh.louisiana.gov/offices/ page. asp?id-264&detail-7901.
24. McNicholl, I.R. (2008). Strategies to enhance adherence, reduce costs, and improve patient quality of life. Journal of Managed Care Pharmacy, 14(5), S12-S16.
25. Medicare.gov (2008). Medicare plan choices overview. Retrieved October 10, 2008, from http://www.medicare. gov/choices/Overview.asp. Medicare Prescription Drug Improvement and Modernization Act of 2003. Public Law 108-173, 117 STAT. 2066.
26. Paul, S., Martin, R., Lu, S., & Lin, Y. (2007). Changing trends in human immuno-deficiency virus and acquired immuno-deficiency syndrome in the population aged 50 and older. Journal of the American Geriatrics Society, 55(9), 1393-1397.
27. Piot, P., Kazatchkine, M., Dybul, M., & Lob-Levyt, J. (2009). AIDS: Lessons learnt and myths dispelled. Early Online Publication, March 20, 2009. Retrieved April 19, 2009, from http://www.thelancet.com/journals/ lancet/article/PllS0140-6736(09)60321-4/fulltext.
28. Project Inform (2000). What's new in treatment information? Retrieved March 15, 2009, from http://www. thebody.com/content/art5198.html. Ryan White Treatment Modernization Act of 2006 Public Law 109-415 amending Title XXVI of the Public Health Service Act.
29. Seattle Treatment Education Project (2000). New guidelines for the use of cholesterol-lowering drugs with HAART. Retrieved July 1, 2008, from http://www.thebody.com/ content/treat/art2092.html.
30. Szirony, T.A. (1999). Infection with HIV in the elderly population. Journal of Gerontological Nursing, 25(10), 25-31.
31. Wongvipat, N. (2001). HAART works! Retrieved July 22, 2009, from http://www.thebody.com/content/treat/ art4826.html.